June 9, 2026) – BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) (“BioMark” or the “Company”), a leading developer of liquid biopsy technologies for early cancer detection, is pleased to ...

Researchers have identified a 14-protein blood signature that may predict lung cancer risk up to five years before diagnosis, ...

A new tool that identifies early cancer risk in patients is currently under review with the Food and Drug Administration (FDA ...

Researchers have developed BayesCNA, a new method that detects cancer DNA at just 5% in blood samples, potentially improving ...

Memorial Sloan Kettering (MSK) Cancer Center and artificial intelligence-driven health tech company Sophia Genetics signed a memorandum of understanding (MOU) to partner on a precision oncology ...

Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before ...

Important mental health history is often present in medical records but hard to find, especially when it is missing from the ...

Researchers have identified a blood signature that can predict lung cancer risk years before diagnosis – significant findings that could enhance ...

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to ...

A biotech company is using dogs and AI-powered breath analysis to improve early cancer detection through non-invasive at-home ...

Researchers at MUSC Hollings Cancer Center have developed a machine learning tool to identify cancer patients who may be at high risk for financial toxicity—the financial stress and hardship that can ...